Lebanon vs East Timor: Cause of death, by non-communicable diseases, female
Lebanon
56.6%
in 2021
East Timor
55.3%
in 2021
Lebanon rank
127th
East Timor rank
130th
Cause of death, by non-communicable diseases, female over time
- Lebanon
- East Timor
How they compare
Lebanon currently reports 56.6% against 55.3% in East Timor, a difference of 1.3%.
Across all 6 years both countries report, Lebanon has been ahead every year.
Lebanon ranks 127th and East Timor ranks 130th of 185 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lebanon | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 82.3% | 28.1% | 54.1% | Lebanon |
| 2010s | 85.3% | 52.3% | 33.0% | Lebanon |
| 2020s | 66.5% | 55.2% | 11.3% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Lebanon or East Timor?
- Lebanon, at 56.6% against 55.3% in East Timor as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Lebanon and East Timor?
- 1.3%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and East Timor?
- 6 years are reported by both, from 2000 to 2021.
- How do Lebanon and East Timor rank globally for cause of death, by non-communicable diseases, female?
- Lebanon ranks 127th and East Timor ranks 130th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.